Supports research and programs that address health disparities and improve outcomes for Black women impacted by triple-negative breast cancer by tackling systemic and social determinants of health.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (annual application deadline, projected)
Funding Amounts: Not specified; varies by project and initiative.
Summary: Supports U.S. organizations advancing health equity for Black women impacted by triple-negative breast cancer by addressing systemic disparities and social determinants of health.
This grant supports U.S.-based organizations working to improve outcomes for Black women disproportionately affected by triple-negative breast cancer (TNBC). The initiative emphasizes addressing health disparities, increasing awareness, enhancing screening, diagnosis, treatment, and survivorship, and tackling structural and social determinants of health—including systemic racism—that contribute to poorer outcomes for this population.